Correlation Between National CineMedia and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both National CineMedia and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining National CineMedia and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between National CineMedia and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on National CineMedia and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in National CineMedia with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of National CineMedia and Artiva Biotherapeutics,.
Diversification Opportunities for National CineMedia and Artiva Biotherapeutics,
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between National and Artiva is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding National CineMedia and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and National CineMedia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on National CineMedia are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of National CineMedia i.e., National CineMedia and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between National CineMedia and Artiva Biotherapeutics,
Given the investment horizon of 90 days National CineMedia is expected to generate 0.49 times more return on investment than Artiva Biotherapeutics,. However, National CineMedia is 2.06 times less risky than Artiva Biotherapeutics,. It trades about 0.09 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about -0.48 per unit of risk. If you would invest 661.00 in National CineMedia on October 28, 2024 and sell it today you would earn a total of 29.00 from holding National CineMedia or generate 4.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
National CineMedia vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| National CineMedia |
| Artiva Biotherapeutics, |
National CineMedia and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with National CineMedia and Artiva Biotherapeutics,
The main advantage of trading using opposite National CineMedia and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if National CineMedia position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| National CineMedia vs. MGO Global Common | National CineMedia vs. Baosheng Media Group | National CineMedia vs. Glory Star New | National CineMedia vs. Impact Fusion International |
| Artiva Biotherapeutics, vs. NETGEAR | Artiva Biotherapeutics, vs. KVH Industries | Artiva Biotherapeutics, vs. Asure Software | Artiva Biotherapeutics, vs. National CineMedia |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stocks Directory Find actively traded stocks across global markets |